ATHE
Price
$4.04
Change
-$0.02 (-0.49%)
Updated
Sep 26, 12:46 PM (EDT)
Capitalization
78.93M
TECX
Price
$15.51
Change
+$0.80 (+5.44%)
Updated
Sep 26, 01:29 PM (EDT)
Capitalization
275.26M
Interact to see
Advertisement

ATHE vs TECX

Header iconATHE vs TECX Comparison
Open Charts ATHE vs TECXBanner chart's image
Alterity Therapeutics
Price$4.04
Change-$0.02 (-0.49%)
Volume$100
Capitalization78.93M
Tectonic Therapeutic
Price$15.51
Change+$0.80 (+5.44%)
Volume$105
Capitalization275.26M
ATHE vs TECX Comparison Chart in %
Loading...
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHE vs. TECX commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a Buy and TECX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ATHE: $4.06 vs. TECX: $14.71)
Brand notoriety: ATHE and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 47% vs. TECX: 94%
Market capitalization -- ATHE: $78.93M vs. TECX: $275.26M
ATHE [@Biotechnology] is valued at $78.93M. TECX’s [@Biotechnology] market capitalization is $275.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATHE and TECX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHE’s TA Score shows that 3 TA indicator(s) are bullish while TECX’s TA Score has 4 bullish TA indicator(s).

  • ATHE’s TA Score: 3 bullish, 4 bearish.
  • TECX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ATHE and TECX are a bad buy in the short-term.

Price Growth

ATHE (@Biotechnology) experienced а -7.35% price change this week, while TECX (@Biotechnology) price change was -5.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($275M) has a higher market cap than ATHE($78.9M). ATHE YTD gains are higher at: 22.598 vs. TECX (-68.139). ATHE has higher annual earnings (EBITDA): -12.19M vs. TECX (-63.29M). TECX has more cash in the bank: 287M vs. ATHE (40.7M). ATHE has less debt than TECX: ATHE (155K) vs TECX (1.94M). ATHE (0) and TECX (0) have equivalent revenues.
ATHETECXATHE / TECX
Capitalization78.9M275M29%
EBITDA-12.19M-63.29M19%
Gain YTD22.598-68.139-33%
P/E RatioN/A3.55-
Revenue00-
Total Cash40.7M287M14%
Total Debt155K1.94M8%
FUNDAMENTALS RATINGS
ATHE vs TECX: Fundamental Ratings
ATHE
TECX
OUTLOOK RATING
1..100
6256
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3994
P/E GROWTH RATING
1..100
10085
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECX's Valuation (23) in the null industry is somewhat better than the same rating for ATHE (86) in the Biotechnology industry. This means that TECX’s stock grew somewhat faster than ATHE’s over the last 12 months.

TECX's Profit vs Risk Rating (100) in the null industry is in the same range as ATHE (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to ATHE’s over the last 12 months.

TECX's SMR Rating (97) in the null industry is in the same range as ATHE (97) in the Biotechnology industry. This means that TECX’s stock grew similarly to ATHE’s over the last 12 months.

ATHE's Price Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for TECX (94) in the null industry. This means that ATHE’s stock grew somewhat faster than TECX’s over the last 12 months.

TECX's P/E Growth Rating (85) in the null industry is in the same range as ATHE (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to ATHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATHETECX
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FUGRF11.870.64
+5.65%
Furgo NV
GPAGF20.62N/A
N/A
Gruma S.A.B. de CV
MAHMF40.50N/A
N/A
Mahindra & Mahindra Ltd.
OPNDF3.01N/A
N/A
Open Door Inc.
GBMCF0.09N/A
N/A
Green Bridge Metals Corporation

ATHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHE has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHE
1D Price
Change %
ATHE100%
-7.56%
EYPT - ATHE
54%
Loosely correlated
-6.32%
SLDB - ATHE
38%
Loosely correlated
-5.13%
TECX - ATHE
35%
Loosely correlated
-1.87%
GHRS - ATHE
31%
Poorly correlated
-3.67%
CVM - ATHE
29%
Poorly correlated
-5.23%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
-1.87%
IGC - TECX
49%
Loosely correlated
-4.38%
SRPT - TECX
35%
Loosely correlated
-2.96%
ATHE - TECX
35%
Loosely correlated
-7.56%
IMNM - TECX
35%
Loosely correlated
-9.33%
DNA - TECX
34%
Loosely correlated
-2.43%
More